Literature DB >> 22270369

Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.

Atsushi Kuga1, Motoi Kanagawa, Atsushi Sudo, Yiumo Michael Chan, Michiko Tajiri, Hiroshi Manya, Yamato Kikkawa, Motoyoshi Nomizu, Kazuhiro Kobayashi, Tamao Endo, Qi L Lu, Yoshinao Wada, Tatsushi Toda.   

Abstract

α-Dystroglycan (α-DG) is a membrane-associated glycoprotein that interacts with several extracellular matrix proteins, including laminin and agrin. Aberrant glycosylation of α-DG disrupts its interaction with ligands and causes a certain type of muscular dystrophy commonly referred to as dystroglycanopathy. It has been reported that a unique O-mannosyl tetrasaccharide (Neu5Ac-α2,3-Gal-β1,4-GlcNAc-β1,2-Man) and a phosphodiester-linked modification on O-mannose play important roles in the laminin binding activity of α-DG. In this study, we use several dystroglycanopathy mouse models to demonstrate that, in addition to fukutin and LARGE, FKRP (fukutin-related protein) is also involved in the post-phosphoryl modification of O-mannose on α-DG. Furthermore, we have found that the glycosylation status of α-DG in lung and testis is minimally affected by defects in fukutin, LARGE, or FKRP. α-DG prepared from wild-type lung- or testis-derived cells lacks the post-phosphoryl moiety and shows little laminin-binding activity. These results show that FKRP is involved in post-phosphoryl modification rather than in O-mannosyl tetrasaccharide synthesis. Our data also demonstrate that post-phosphoryl modification not only plays critical roles in the pathogenesis of dystroglycanopathy but also is a key determinant of α-DG functional expression as a laminin receptor in normal tissues and cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270369      PMCID: PMC3308745          DOI: 10.1074/jbc.M111.271767

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  N-terminal alpha-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells.

Authors:  Heike Hall; Damir Bozic; Kathrin Michel; Jeffrey A Hubbell
Journal:  Mol Cell Neurosci       Date:  2003-12       Impact factor: 4.314

Review 2.  Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function.

Authors:  Daniel E Michele; Kevin P Campbell
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

3.  Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation.

Authors:  Ariana C Combs; James M Ervasti
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.

Authors:  J van Reeuwijk; M Janssen; C van den Elzen; D Beltran-Valero de Bernabé; P Sabatelli; L Merlini; M Boon; H Scheffer; M Brockington; F Muntoni; M A Huynen; A Verrips; C A Walsh; P G Barth; H G Brunner; H van Bokhoven
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

Review 5.  Dystroglycanopathies: coming into focus.

Authors:  Caroline Godfrey; A Reghan Foley; Emma Clement; Francesco Muntoni
Journal:  Curr Opin Genet Dev       Date:  2011-03-11       Impact factor: 5.578

6.  Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Authors:  Chris J Moore; Steve J Winder
Journal:  Cell Commun Signal       Date:  2010-02-17       Impact factor: 5.712

7.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Authors:  Daniel E Michele; Rita Barresi; Motoi Kanagawa; Fumiaki Saito; Ronald D Cohn; Jakob S Satz; James Dollar; Ichizo Nishino; Richard I Kelley; Hannu Somer; Volker Straub; Katherine D Mathews; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

8.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy.

Authors:  K Kobayashi; Y Nakahori; M Miyake; K Matsumura; E Kondo-Iida; Y Nomura; M Segawa; M Yoshioka; K Saito; M Osawa; K Hamano; Y Sakakihara; I Nonaka; Y Nakagome; I Kanazawa; Y Nakamura; K Tokunaga; T Toda
Journal:  Nature       Date:  1998-07-23       Impact factor: 49.962

9.  O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.

Authors:  Takako Yoshida-Moriguchi; Liping Yu; Stephanie H Stalnaker; Sarah Davis; Stefan Kunz; Michael Madson; Michael B A Oldstone; Harry Schachter; Lance Wells; Kevin P Campbell
Journal:  Science       Date:  2010-01-01       Impact factor: 47.728

10.  Dystroglycan matrix receptor function in cardiac myocytes is important for limiting activity-induced myocardial damage.

Authors:  Daniel E Michele; Zhyldyz Kabaeva; Sarah L Davis; Robert M Weiss; Kevin P Campbell
Journal:  Circ Res       Date:  2009-09-24       Impact factor: 17.367

View more
  13 in total

1.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

2.  Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.

Authors:  Charles H Vannoy; Lei Xu; Elizabeth Keramaris; Pei Lu; Xiao Xiao; Qi Long Lu
Journal:  Hum Gene Ther Methods       Date:  2014-05-02       Impact factor: 2.396

Review 3.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

4.  Golgi phosphoprotein 3 mediates the Golgi localization and function of protein O-linked mannose β-1,2-N-acetlyglucosaminyltransferase 1.

Authors:  Natasha A Pereira; Helen X Pu; Hazel Goh; Zhiwei Song
Journal:  J Biol Chem       Date:  2014-04-14       Impact factor: 5.157

Review 5.  Cystic kidneys in fetal Walker-Warburg syndrome with POMT2 mutation: Intrafamilial phenotypic variability in four siblings and review of literature.

Authors:  Marwa M Nabhan; Nour ElKhateeb; Daniela A Braun; Sungho Eun; Sahar N Saleem; Heon YungGee; Friedhelm Hildebrandt; Neveen A Soliman
Journal:  Am J Med Genet A       Date:  2017-08-17       Impact factor: 2.802

6.  Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.

Authors:  Chunping Qiao; Chi-Hsien Wang; Chunxia Zhao; Peijuan Lu; Hiroyuki Awano; Bin Xiao; Jianbin Li; Zhenhua Yuan; Yi Dai; Carrie Bette Martin; Juan Li; Qilong Lu; Xiao Xiao
Journal:  Mol Ther       Date:  2014-07-22       Impact factor: 11.454

Review 7.  Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.

Authors:  David Live; Lance Wells; Geert-Jan Boons
Journal:  Chembiochem       Date:  2013-11-07       Impact factor: 3.164

8.  Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.

Authors:  Aaron M Beedle; Amy J Turner; Yoshiaki Saito; John D Lueck; Steven J Foltz; Marisa J Fortunato; Patricia M Nienaber; Kevin P Campbell
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

9.  AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.

Authors:  Hirokazu Yagi; Naoki Nakagawa; Takuya Saito; Hiroshi Kiyonari; Takaya Abe; Tatsushi Toda; Sz-Wei Wu; Kay-Hooi Khoo; Shogo Oka; Koichi Kato
Journal:  Sci Rep       Date:  2013-11-21       Impact factor: 4.379

10.  Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophy.

Authors:  Motoi Kanagawa; Zhongpeng Lu; Chiyomi Ito; Chie Matsuda; Katsuya Miyake; Tatsushi Toda
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.